Pete YanulHuntsville, Ala. — August 19, 2014 — HudsonAlpha Institute for Biotechnology is pleased to announce the appointment of Peter Yanul as the new vice president for finance and strategy. He joined the Institute on August 18, 2014.

“Pete has a truly impressive track record with diverse financial management experience and is the ideal candidate to help the Institute grow and establish itself as an international leader in research, educational, and commercial applications within the life sciences,” said Richard M. Myers, president and science director of HudsonAlpha. “In previous roles, Pete has proven himself a key member of leadership teams — driving financial planning and analysis, modeling, strategic and tactical planning, and performance management. His extensive, on-point experience will provide critical support for HudsonAlpha as it expands its sequencing services for clinical applications.”

A native New Yorker, Yanul has more than 25 years of diverse financial management experience and spent the last 10 years in the biotech and medical device industries. Yanul previously served in financial leadership roles at Nektar Therapeutics and Open Biosystems/Thermo Fisher Scientific.

“This is an exciting time to be joining HudsonAlpha, as the Institute prepares to take its next steps. Having worked for two biotech companies in Huntsville affiliated with the Institute, I have seen firsthand how the work performed here can have a profound effect on people’s lives. For those reasons I would consider this job a dream come true,” said Yanul.

“It’s my goal to ensure that the proper business framework, processes and tools are in place to support day-to-day decision-making and guide strategic direction as the organization accelerates its growth. I feel honored to be joining an excellent leadership team and look forward to contributing to the continued success of the Institute,” he added.

Media Contact: Heather Smith
communications@hudsonalpha.org
256-327-9508

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological problems. Its mission is three-fold: sparking scientific discoveries that can impact human health and well-being; fostering biotech entrepreneurship; and encouraging the creation of a genomics-literate workforce and society. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. Designed to be a hothouse of biotech economic development, HudsonAlpha’s state-of-the-art facilities co-locate scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus allow serendipity to yield results in medicine and agriculture. Since opening in 2008, HudsonAlpha, under the leadership of Dr. Richard M. Myers, a key collaborator on the Human Genome Project, has built a name for itself in genetics and genomics research and biotech education, and boasts 27 biotech companies on campus.